Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ambry Genetics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011828
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ambry Genetics Corp (Ambry Genetics) is a biotechnology company that offers genetic testing services. The company offers clinical diagnostics services, which include tests, forms, billing, managed care, order kits, reporting, licenses, family studies program, variant classification and secure file upload. It offers clinical resources such as cancer test overview videos, webinars, clinical tools, clinician guides, other publications, and ambryport 2.0 tutorial videos. The company also provides patient resources for cancer, cardiology, exome, general genetics, neurology, and microarray. Ambry Genetics is headquartered in Aliso Viejo, California, the US.

Ambry Genetics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ambry Genetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ambry Genetics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 11
Partnerships 13
Cell Line Genetics Enters Into Co-Marketing Agreement With Ambry Genetics 13
Acquisition 14
Konica Minolta Acquires Ambry Genetics 14
Ambry Genetics Acquires Progeny Software 16
Ambry Genetics Corp – Key Competitors 17
Ambry Genetics Corp – Key Employees 18
Ambry Genetics Corp – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Feb 18, 2016: Ambry Genetics Unveils Its Super Lab, One of the Largest, Most State-of-the-Art Commercial Laboratories in the World 20
Corporate Communications 22
Mar 24, 2016: Charles Dunlop of Ambry Genetics Assumes Role of President; Dr. Aaron Elliott Named CEO 22
Government and Public Interest 23
Apr 18, 2017: Ambry Genetics Recruits Patient Cohorts to Discover New Links between Genes and Autism 23
Product News 24
Mar 08, 2016: Ambry Genetics Launches AmbryShare, the Largest Disease-Specific Public Database of Sequenced Human Genomes, Increasing the Understanding of Hereditary Breast and Ovarian Cancer 10 Fold 24
Other Significant Developments 26
Feb 21, 2017: Ambry Genetics Launches New Site for Cohort Recruitment 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Key Facts 2
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ambry Genetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ambry Genetics Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Ambry Genetics Corp, Medical Devices Deals, 2011 to YTD 2017 9
Ambry Genetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ambry Genetics Acquires ThunderStorm System From RainDance Technologies 11
Cell Line Genetics Enters Into Co-Marketing Agreement With Ambry Genetics 13
Konica Minolta Acquires Ambry Genetics 14
Ambry Genetics Acquires Progeny Software 16
Ambry Genetics Corp, Key Competitors 17
Ambry Genetics Corp, Key Employees 18
Ambry Genetics Corp, Subsidiaries 19

★海外企業調査レポート[Ambry Genetics Corp-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Esperion Therapeutics Inc (ESPR):企業の財務・戦略的SWOT分析
    Summary Esperion Therapeutics Inc (Esperion), a subsidiary of Pfizer Inc is a pharmaceutical company that develops and commercializes once-daily, oral and low-density lipoprotein cholesterol lowering therapies. The company develops oral therapies to treat patients with elevated low-density lipoprote …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • permanent tsb Group Holdings p.l.c.:企業の戦略・SWOT・財務情報
    permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report Summary permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Premiere Global Services, Inc.:企業の戦略的SWOT分析
    Premiere Global Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Immucor, Inc.-医療機器分野:企業M&A・提携分析
    Summary Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to …
  • Hdfc Bank Ltd:企業の戦略・SWOT・財務分析
    Hdfc Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Hdfc Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Michelin SCA (ML):企業の財務・戦略的SWOT分析
    Michelin SCA (ML) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • National OilWell Varco, Inc.:企業の戦略・SWOT・財務情報
    National OilWell Varco, Inc. - Strategy, SWOT and Corporate Finance Report Summary National OilWell Varco, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Azul SA (AZUL4):企業の財務・戦略的SWOT分析
    Azul SA (AZUL4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Navistar Defense, LLC:企業の戦略・SWOT・財務情報
    Navistar Defense, LLC - Strategy, SWOT and Corporate Finance Report Summary Navistar Defense, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SEEK Limited:企業のM&A・事業提携・投資動向
    SEEK Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SEEK Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Kopin Corp (KOPN):企業の財務・戦略的SWOT分析
    Summary Kopin Corp (Kopin) is a technology company that offers wearable technologies and solutions. The company’s products comprise wearable headsets, transmissive liquid crystal displays, batteries, ASIC products, module products, whisper voice chip among others. Kopin technologies and solutions he …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • Australia and New Zealand Banking Group Ltd:企業の戦略・SWOT・財務情報
    Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Australia and New Zealand Banking Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Vivakor Inc (VIVK):石油・ガス:M&Aディール及び事業提携情報
    Summary Vivakor Inc (Vivakor) is a technology and asset acquisition company that creates, acquires and accumulates distinct assets, intellectual properties, and various technologies. The company concentrates on precious metals extraction in the US. It also concentrates on oil extraction from shallow …
  • Optimum General Inc.
    Optimum General Inc. - Strategy, SWOT and Corporate Finance Report Summary Optimum General Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ashok Leyland Ltd (ASHOKLEY):企業の財務・戦略的SWOT分析
    Ashok Leyland Ltd (ASHOKLEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Angelique International Ltd:企業の戦略・SWOT・財務情報
    Angelique International Ltd - Strategy, SWOT and Corporate Finance Report Summary Angelique International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Onxeo SA (ONXEO):企業の財務・戦略的SWOT分析
    Summary Onxeo SA (Onxeo) is a manufacturer of drugs that offers development, and registration of orphan oncology drugs for the treatment of cancer. The company provides pipeline products such as beleodaq and asidna among others. It offers drugs for the treatment of liver cancer, and treatment and pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆